Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation.
about
Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgammaPPARgamma agonists inhibit TGF-beta-PKA signaling in glomerulosclerosis.A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responsesPPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesisAdiponectin is an endogenous anti-fibrotic mediator and therapeutic target.Homocysteine and Hypertension in Diabetes: Does PPARgamma Have a Regulatory Role?Activation of PPARs α, β/δ, and γ Impairs TGF-β1-Induced Collagens' Production and Modulates the TIMP-1/MMPs Balance in Three-Dimensional Cultured Chondrocytes.Involvement of PPAR nuclear receptors in tissue injury and wound repairGlomerular aging in females is a multi-stage reversible process mediated by phenotypic changes in progenitors.The glomerulosclerosis of aging in females: contribution of the proinflammatory mesangial cell phenotype to macrophage infiltration.Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma.Growth factors and the development of diabetic nephropathy.Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study.hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.Resistance to glomerulosclerosis in B6 mice disappears after menopause.Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosisAntidiabetic effects of Corni Fructus extract in streptozotocin-induced diabetic ratsRegulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis.The role of nuclear receptors in the kidney in obesity and metabolic syndromeProtective effect of peroxisome proliferator activated receptor gamma agonists on diabetic and non-diabetic renal diseases.PPAR-gamma agonists and diabetic nephropathy.Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblastsMicroRNA-27a Induces Mesangial Cell Injury by Targeting of PPARγ, and its In Vivo Knockdown Prevents Progression of Diabetic NephropathyPPARs and the kidney in metabolic syndrome.Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly personsPeroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator.Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.Fibrosis in systemic sclerosis: emerging concepts and implications for targeted therapy.The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes.Molecular basis of organ fibrosis: potential therapeutic approaches.Complexity of diabetic nephropathy pathogenesis and design of investigations.The role of PPARγ-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology.Lipotoxicity as a trigger factor of renal disease.Peroxisome proliferator activating receptor-γ and the podocyte.Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway.Inhibitory effects of peroxisome proliferator-activated receptor γ agonists on collagen IV production in podocytes.Structurally Programmed Assembly of Translation Initiation Nanoplex for Superior mRNA Delivery.Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.Omacor, n-3 polyunsaturated fatty acid, attenuated albuminuria and renal dysfunction with decrease of SREBP-1 expression and triglyceride amount in the kidney of type II diabetic animals.A biodegradable polyurethane-ascorbic acid scaffold for bone tissue engineering.
P2860
Q28567488-D1FE97C9-0228-4009-9862-D92C8F2BF5F7Q33520918-4768338A-D8E8-4317-8DFF-02EE3B4C8F6AQ33637862-912F43C7-CEF7-4E2D-A60E-2C90B045CE8DQ33745028-61852842-8077-4C5B-9FB3-7F22E0389091Q33860888-25DC86BA-BC8D-4261-B736-C63A753694D9Q33953983-65CAFDB6-169B-45EF-BD7F-FADD5024A8FEQ34210856-CD81FF09-5623-41F4-8D15-276B4B97AC7DQ34416422-9CBDC43C-9069-481A-8A2B-7635B68F7B46Q35085046-D06B0316-F6A3-4C92-8DF2-0090A9728DD2Q35103388-26572BF6-8164-4697-9E1F-912205932818Q35170133-84AAC671-8D98-482C-BF65-CC7C80E27F23Q35581294-3C054F2E-95A1-4417-9882-5F0671A920A3Q35665975-1A2F5DAB-3627-4039-939D-FCA447C4B2B7Q35677086-95C2F4DD-27BB-4B7F-AD58-DF0112D6C63EQ35749183-23C8DBAC-DA3C-418A-A0FB-0EE9D1A67913Q35954579-A4F8BC31-4E12-4A84-8074-9FA267F00FCEQ36053411-F704A3AF-4AA9-4381-8061-8D9884DE7A84Q36093802-A993A472-872E-4B32-AF49-FD40B96BB340Q36250127-88CEF369-8A1D-468E-9C47-2C07BA63346AQ36262404-AFB9651F-2473-4A0A-8470-1442D714891FQ36326399-1E6442FE-76FC-48BC-8590-392FB5229C5EQ36417662-108DFBCF-7ACC-4738-8F31-84A8F1BA795BQ36906818-C9098E71-1F11-4504-97CD-56DABEBF575FQ37072216-13106190-4FFA-4DBD-8E75-D86ECD5493E8Q37214116-D8F62FF3-D8BC-4E36-B0BA-BD7960AA5DEFQ37326935-9EE4ECAA-55BF-4E19-90F6-2A4BBBA1535AQ37638268-31C08739-55C4-47C5-8264-370C9D71B892Q37721063-70E7AD53-6A98-4DF3-B64E-B9643A3FD1E9Q37997004-C7FE2554-131C-4120-960A-7B999274EB8DQ38121751-1F4A4E48-F2FA-49B0-A0C5-AF00566B3ECDQ38262136-69A48196-4286-49A2-86E4-83BF7FA7DB74Q38341507-EEAFFA7E-2731-42C1-8231-2B893B80B4EFQ38765934-418C4506-B729-48B2-91AF-EC9A009DC58AQ38815188-DCB0F7E5-FA7E-4E93-B4BB-D856C9FC4C31Q39504273-3E53DE09-CE5E-4003-9E1B-8F6B70B6D5B9Q41004141-68A4CF62-83FE-4F82-97C2-A354FE7422F5Q42276001-6A42FAF0-6A7F-42D1-AA2F-FDAB0E9EE992Q42459998-D2B7E478-78EE-440B-84D9-17959AEE2C25Q43204665-869A3853-2C82-4C4B-9F46-8833FD9DFE7FQ44623506-3E4311AB-20E3-4A10-BEF8-5726F7C53480
P2860
Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Upregulation of type I collage ...... ocked by PPARgamma activation.
@en
Upregulation of type I collage ...... ocked by PPARgamma activation.
@nl
type
label
Upregulation of type I collage ...... ocked by PPARgamma activation.
@en
Upregulation of type I collage ...... ocked by PPARgamma activation.
@nl
prefLabel
Upregulation of type I collage ...... ocked by PPARgamma activation.
@en
Upregulation of type I collage ...... ocked by PPARgamma activation.
@nl
P2093
P2860
P1476
Upregulation of type I collage ...... ocked by PPARgamma activation.
@en
P2093
Alessia Fornoni
Feng Zheng
Gary E Striker
Liliane J Striker
Matthew D Breyer
Sharon J Elliot
Youfei Guan
P2860
P304
P356
10.1152/AJPRENAL.00189.2001
P577
2002-04-01T00:00:00Z